Show simple item record

dc.creatorRuiz Narváez, Edward A.
dc.creatorSacks, Frank M.
dc.creatorCampos Núñez, Hannia
dc.date.accessioned2020-07-03T20:00:17Z
dc.date.available2020-07-03T20:00:17Z
dc.date.issued2008
dc.identifier.citationhttps://academic.oup.com/ajcn/article/87/6/1932/4633423?searchresult=1es_ES
dc.identifier.issn0002-9165
dc.identifier.issn1938-3207
dc.identifier.urihttp://hdl.handle.net/10669/81271
dc.description.abstractBackground: Plasma apolipoprotein (apo) C-III strongly predicts myocardial infarction (MI) and directly activates atherogenic processes in vascular cells. Genetic variation in the insulin response element of the APOC3 promoter is associated with an increased risk of MI. Objective: The objective was to determine whether the APOC3 promoter variation affects plasma apo C-III concentrations and MI only when insulin sensitivity is normal. Design: The APOC3*222 haplotype, defined by the minor alleles of the single nucleotide polymorphisms 3238C→G, −455T→C, and −482C→T, was studied in 1703 matched nonfatal case-control pairs with MI in the Central Valley of Costa Rica. We used fasting hyperglycemia and abdominal obesity as surrogates for insulin sensitivity. Results: The APOC3*222 haplotype was associated with higher apo C-III concentrations only in those with the lowest waist circumference or fasting glucose concentration. The association between the APOC3*222 haplotype and nonfatal MI, previously reported in this population, was strongly influenced by fasting hyperglycemia and abdominal obesity. The odds ratios for MI for the APOC3*222 haplotype were 1.72 (95% CI: 1.16, 2.54) and 1.84 (1.31, 2.59) in subjects in the lowest quintiles of abdominal obesity and fasting hyperglycemia, respectively, and were 0.75 (0.54, 1.05) and 1.16 (0.85, 1.59) in subjects in the highest quintiles, respectively (P for interaction <0.05). Conclusion: The results support the concept that mutations in the APOC3 promoter inhibit the down-regulation of APOC3 expression by insulin. This cardioprotective system becomes dysfunctional in abdominal obesity and hyperglycemia.es_ES
dc.language.isoen_USes_ES
dc.sourceThe American Journal of Clinical Nutrition, vol.87(6), pp.1932-1938es_ES
dc.subjectObesidades_ES
dc.subjectEnfermedades cardiovasculareses_ES
dc.subjectInfarto de miocardioes_ES
dc.subjectGenéticaes_ES
dc.subjectObesityes_ES
dc.subjectMyocardial infarctiones_ES
dc.subjectGeneticses_ES
dc.titleAbdominal obesity and hyperglycemia mask the effect of a common APOC3 haplotype on the risk of myocardial infarctiones_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doi10.1093/ajcn/87.6.1932
dc.description.procedenceUCR::Vicerrectoría de Investigación::Unidades de Investigación::Ciencias Sociales::Centro Centroamericano de Población (CCP)es_ES


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record